{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:37:10Z","timestamp":1793093830902,"version":"4.5.0"},"reference-count":75,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1136\/dtb.2024.000059","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:20:53Z","timestamp":1782926453000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-lowering for people with chronic kidney disease: a narrative review"],"prefix":"10.1136","volume":"64","clinical-trial-number":[{"clinical-trial-number":"nct04397653","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02275156","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04659525","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3270-3475","authenticated-orcid":false,"given":"David J","family":"Tunnicliffe","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Centre for Kidney Research, The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathika","family":"Krishnasamy","sequence":"additional","affiliation":[{"name":"Australasian Kidney Trials Network, The University of Queensland, Brisbane, Queensland, Australia"},{"name":"Griffith University, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Department of Precision and Regenerative Medicine and Ioninan Area (DIMEPRE-J), University of Bari, Bari, Apulia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026102702151847000_64.11.166.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00519-5"},{"key":"2026102702151847000_64.11.166.2","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990\u20132023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"The Lancet"},{"key":"2026102702151847000_64.11.166.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.04.011"},{"key":"2026102702151847000_64.11.166.4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.kint.2024.11.028","article-title":"International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations eGFR epidemiology (DEGREE) study","volume":"107","author":"Rutter","year":"2025","journal-title":"Kidney Int"},{"key":"2026102702151847000_64.11.166.5","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac104"},{"key":"2026102702151847000_64.11.166.6","first-page":"657","article-title":"Overdiagnosis of CKD in Older Adults: Unnecessary Interventions, Costs, and Worry","volume":"107","author":"Roth","year":"2023","journal-title":"Am Fam Physician"},{"key":"2026102702151847000_64.11.166.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"2026102702151847000_64.11.166.8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.536"},{"key":"2026102702151847000_64.11.166.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00616-6"},{"key":"2026102702151847000_64.11.166.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"2026102702151847000_64.11.166.11","first-page":"S79","article-title":"US Renal Data System 2018 Annual Data Report. Chapter 4. Cardiovascular Disease in patients with CKD","volume":"73","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026102702151847000_64.11.166.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003"},{"key":"2026102702151847000_64.11.166.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61778-4"},{"key":"2026102702151847000_64.11.166.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1619"},{"key":"2026102702151847000_64.11.166.15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs058"},{"key":"2026102702151847000_64.11.166.16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012080870"},{"key":"2026102702151847000_64.11.166.17","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009121285"},{"key":"2026102702151847000_64.11.166.18","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.12.030"},{"key":"2026102702151847000_64.11.166.19","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(82)91513-6"},{"key":"2026102702151847000_64.11.166.20","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.62"},{"key":"2026102702151847000_64.11.166.21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.9.1908"},{"key":"2026102702151847000_64.11.166.22","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.184"},{"key":"2026102702151847000_64.11.166.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002017"},{"key":"2026102702151847000_64.11.166.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.03.055"},{"key":"2026102702151847000_64.11.166.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"2026102702151847000_64.11.166.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69472-5"},{"key":"2026102702151847000_64.11.166.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900241"},{"key":"2026102702151847000_64.11.166.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.11.043"},{"key":"2026102702151847000_64.11.166.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.020"},{"key":"2026102702151847000_64.11.166.30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(95)90926-5","article-title":"Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)","volume":"345","year":"1995","journal-title":"The Lancet"},{"key":"2026102702151847000_64.11.166.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.03.031"},{"key":"2026102702151847000_64.11.166.32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143892.84582.60"},{"key":"2026102702151847000_64.11.166.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200202143460721"},{"key":"2026102702151847000_64.11.166.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"2026102702151847000_64.11.166.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02610-4"},{"key":"2026102702151847000_64.11.166.36","doi-asserted-by":"crossref","unstructured":"Tunnicliffe DJ , Palmer SC , Cashmore BA , et al . HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2023;2023. doi:10.1002\/14651858.CD007784.pub3","DOI":"10.1002\/14651858.CD007784.pub3"},{"key":"2026102702151847000_64.11.166.37","doi-asserted-by":"crossref","first-page":"804000","DOI":"10.3389\/fphar.2021.804000","article-title":"The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study","volume":"12","author":"Tsai","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026102702151847000_64.11.166.38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39906","article-title":"Statin therapy associated mortality in hyperlipidemic dialysis patients with percutaneous coronary intervention for acute myocardial infarction, a retrospective cohort study","volume":"10","author":"Yeh","year":"2024","journal-title":"Heliyon"},{"key":"2026102702151847000_64.11.166.39","doi-asserted-by":"crossref","unstructured":"Palmer SC , Navaneethan SD , Craig JC , et al . n.d. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev 2014. doi:10.1002\/14651858.CD004289.pub5","DOI":"10.1002\/14651858.CD004289.pub5"},{"key":"2026102702151847000_64.11.166.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810177"},{"key":"2026102702151847000_64.11.166.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545"},{"key":"2026102702151847000_64.11.166.42","doi-asserted-by":"publisher","DOI":"10.1159\/000077704"},{"key":"2026102702151847000_64.11.166.43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144121","article-title":"Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating \u03b1-Klotho Concentrations","volume":"11","author":"Adema","year":"2016","journal-title":"PLoS One"},{"key":"2026102702151847000_64.11.166.44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093131"},{"key":"2026102702151847000_64.11.166.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"2026102702151847000_64.11.166.46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2169\/internalmedicine.53.0649","article-title":"Renal and vascular protective effects of ezetimibe in chronic kidney disease","volume":"53","author":"Morita","year":"2014","journal-title":"Intern Med"},{"key":"2026102702151847000_64.11.166.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.049"},{"key":"2026102702151847000_64.11.166.48","first-page":"39","article-title":"Deterioration in renal function associated with fibrate therapy","volume":"55","author":"Lipscombe","year":"2001","journal-title":"Clin Nephrol"},{"key":"2026102702151847000_64.11.166.49","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-8-201204170-00401"},{"key":"2026102702151847000_64.11.166.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1975.03240160024021"},{"key":"2026102702151847000_64.11.166.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.12.007"},{"key":"2026102702151847000_64.11.166.52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11255-013-0559-z","article-title":"Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis","volume":"46","author":"He","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"2026102702151847000_64.11.166.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01938.x"},{"key":"2026102702151847000_64.11.166.54","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07341009"},{"key":"2026102702151847000_64.11.166.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107579"},{"key":"2026102702151847000_64.11.166.56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013543","article-title":"Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants","volume":"8","author":"Hu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026102702151847000_64.11.166.57","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11374"},{"key":"2026102702151847000_64.11.166.58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.jrn.2020.04.004","article-title":"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease","volume":"31","author":"Bunout","year":"2021","journal-title":"J Ren Nutr"},{"key":"2026102702151847000_64.11.166.59","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32832e1bd9"},{"key":"2026102702151847000_64.11.166.60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamainternmed.2016.8029","article-title":"Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial","volume":"177","author":"Irish","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026102702151847000_64.11.166.61","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055560"},{"key":"2026102702151847000_64.11.166.62","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01230122"},{"key":"2026102702151847000_64.11.166.63","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1093\/eurheartj\/ehaa498","article-title":"Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial","volume":"41","author":"Tu\u00f1\u00f3n","year":"2020","journal-title":"Eur Heart J"},{"key":"2026102702151847000_64.11.166.64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2019.07.008","article-title":"Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control","volume":"288","author":"Vallejo-Vaz","year":"2019","journal-title":"Atherosclerosis"},{"key":"2026102702151847000_64.11.166.65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803917"},{"key":"2026102702151847000_64.11.166.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215024"},{"key":"2026102702151847000_64.11.166.67","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.jacc.2023.10.007","article-title":"Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials","volume":"82","author":"Wright","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026102702151847000_64.11.166.68","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2023.10.018"},{"key":"2026102702151847000_64.11.166.69","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.31"},{"key":"2026102702151847000_64.11.166.70","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"2026102702151847000_64.11.166.71","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/nep.14295","article-title":"Australian and New Zealand Living Guideline cholesterol-lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence-practice gap","volume":"29","author":"Cashmore","year":"2024","journal-title":"Nephrology (Carlton)"},{"key":"2026102702151847000_64.11.166.72","first-page":"745","article-title":"The Management of Non\u2013Dialysis-Dependent Chronic Kidney Disease in Primary Care","volume":"117","author":"Weckmann","year":"2020","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"2026102702151847000_64.11.166.73","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi880"},{"key":"2026102702151847000_64.11.166.74","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2016.4652","article-title":"Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies","volume":"2","author":"Bansal","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026102702151847000_64.11.166.75","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1511-x"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2024.000059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:15:36Z","timestamp":1793092536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2024.000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":75,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,27]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/dtb.2024.000059"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2024.000059","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}